Drug product movers & shakers advertising in professional health journals in Q1 2013

Among the top 25 drugs products that are advertising in professional health journals in the first quarter of 2013, these are the five fastest growing in terms of dollars spent compared to the same time period of 2012.

Print Ad Drug Products with Large Increases in Dollars Spent: Jan. – Mar. 2013

  1. Zytiga - $1.4 MM (+72%)
  2. Lyrica Capsules - $1.2 MM (+53%)
  3. Eliquis Tablets - $767,000 (+14,625%)
  4. Zytiga-NB - $696,000 (+181%)
  5. Novo Nordisk Dynamic Management of Diabetes Mellitus - $695,000 (+7,706%)

Note that this does not include products that have launched since February 2012. The percentage changes compare Q1 2013 to Q1 2012. For more information on these ad insights or other data, let one of us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.




Search article